Sunshine Biopharma Stock Forecast for 2023 - 2025 - 2030
Updated on 05/05/2024
Sunshine Biopharma Stock Forecast and Price Target
According to esteemed experts, the average price target for Sunshine Biopharma to reach this year is $15.00, with a potential upside of approximately 1685.71%. This prediction is based on a high estimate of $15.00 and a low estimate of $15.00.
1685.71% Upside
Sunshine Biopharma Revenue Forecast for 2023 - 2025 - 2030
Sunshine Biopharma's Revenue has seen impressive growth In the last two years, rising from $70.00k to $4.35M – a growth of 6114.29%. According to 0 analysts, Sunshine Biopharma's Revenue will fall by 86.33% in the next year, reaching $594.65k. For the next eight years, the forecast is for Revenue to grow by 93.07%.
.jpg)
Sunshine Biopharma EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Sunshine Biopharma's EBITDA has seen an increase, rising from $-560.00k to $-8.65M. This represents a growth of 1444.64%. For the following year, the 0 analysts predict that Sunshine Biopharma's EBITDA will drop by 73.59%, reaching $-2.28M. In 2030, the professionals' prediction is that SBFM's EBITDA will decrease by 22.18%, reaching $-6.73M.
Sunshine Biopharma EBIT Forecast for 2023 - 2025 - 2030
Sunshine Biopharma's EBIT has seen growth In the last two years, going from $-580.00k to $-8.67M – a gain of 1394.83% In the following year, the 0 analysts surveyed believe that Sunshine Biopharma's EBIT will decrease by 73.32%, reaching $-2.31M. According to professionals, by 2030, Sunshine Biopharma's EBIT will have decreased by 22.80%, falling down to $-6.69M.
.jpg)